Stephen T. Worland Ph.D.
Net Worth

Last updated:

What is Stephen T. Worland Ph.D. net worth?

The estimated net worth of Dr. Stephen T. Worland Ph.D. is at least $1,935,793 as of 11 Aug 2023. He owns shares worth $43 as insider and has received compensation worth at least $1,935,750 in eFFECTOR Therapeutics, Inc..

What is the salary of Stephen T. Worland Ph.D.?

Dr. Stephen T. Worland Ph.D. salary is $645,250 per year as Chief Executive Officer, Pres & Director in eFFECTOR Therapeutics, Inc..

How old is Stephen T. Worland Ph.D.?

Dr. Stephen T. Worland Ph.D. is 67 years old, born in 1958.

What stocks does Stephen T. Worland Ph.D. currently own?

As insider, Dr. Stephen T. Worland Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
eFFECTOR Therapeutics, Inc. (EFTR) Chief Executive Officer, Pres & Director 214,978 $0 $43

What does eFFECTOR Therapeutics, Inc. do?

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.

Stephen T. Worland Ph.D. insider trading

eFFECTOR Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 33,799 $0.52 $17,575
Option
Common Stock 33,799 $0.52 $17,575
Purchase
Common Stock 20,000 $1.37 $27,400

eFFECTOR Therapeutics key executives

eFFECTOR Therapeutics, Inc. executives and other stock owners filed with the SEC: